New bill gives hospitals power to develop personalised treatment

Thursday, 13 February 2020

NHS hospitals will be able to use innovative, personalised medicines for unique cancers and diseases, following the introduction of the Medicines and Medical Devices Bill this week.

The new bill means hospitals can use patient tissue and DNA samples to tailor treatments to individual patients when other medicines have failed, or to develop drugs that have a shelf-life of minutes and would otherwise be unavailable to them. This has the potential to streamline access to treatments for patients with rare cancers and brain tumours.